BDSI closes $50M equity financing – here’s what its board looks like now

Raleigh ’s BioDelivery Sciences International has closed its $50 million equity financing – led by New York-based global equity manager Broadfin Capital – banking net proceeds of $48.9 million.  “It’s going to be applied in ways in which we can best accelerate the sales of Belbuca,” said BDSI’ s recently retired president and CEO, Mark Sirgo, of the equity financing shortly after it was announced this past Friday. BDSI (Nasdaq: BDSI) reacquired pain management product Belbuca at the…
Source: bizjournals.com Health Care:Physician Practices headlines - Category: American Health Authors: Source Type: news